{
    "2021-01-27": [
        [
            {
                "time": "2021-01-27",
                "original_text": "泰格医药：预计2020年净利润同比增长100%-115%",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "净利润",
                        "同比增长",
                        "100%",
                        "115%"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-01-27",
                "original_text": "【权益变动】泰格医药(03347-HK)被贝莱德减持24.82万股 减持股份",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "贝莱德",
                        "减持",
                        "24.82万股"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-27",
                "original_text": "万联证券-CRO行业深度报告：创新药大时代，CRO乘风起舞【行业研究】",
                "features": {
                    "keywords": [
                        "CRO行业",
                        "创新药",
                        "深度报告",
                        "万联证券"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-01-27",
                "original_text": "高瓴资本概念股走势分化，国瓷材料、健帆生物、泰格医药均下滑",
                "features": {
                    "keywords": [
                        "高瓴资本",
                        "泰格医药",
                        "下滑",
                        "国瓷材料",
                        "健帆生物"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO行业"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-27",
                "original_text": "港股异动︱泰格医药(03347)跌超6% 遭FIDELITY INVESTMENT TRUST减持17.4万股 共涉资约3119.13万元 减持股份数量",
                "features": {
                    "keywords": [
                        "泰格医药",
                        "港股",
                        "异动",
                        "FIDELITY INVESTMENT TRUST",
                        "减持",
                        "17.4万股"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-01-27",
                "original_text": "中信建投：节前看好年报行情及疫情受益主线",
                "features": {
                    "keywords": [
                        "中信建投",
                        "年报行情",
                        "疫情受益",
                        "节前"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗",
                        "CRO行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}